BLOG
Latest Research & Guides
Educational, research-backed articles about peptides, clinical trials, safety, and practical guides.
How to Store Peptides: Refrigeration, Freezing, and Real Shelf Life Explained | Peptadex
Peptide stability depends on temperature, reconstitution status, and bacteriostatic water choice. A research-based guide to peptide storage and shelf life in 2026.
Why Isn't Ozempic Working For Me? GLP-1 Resistance and the GLP1R Gene Explained | Peptadex
A 2026 Stanford and Nature study identified a genetic variant predicting GLP-1 weight loss response. Here's what GLP-1 resistance means and what to do about it.
GLP-1 for Alcohol and Addiction: What 15+ Active Clinical Trials Are Actually Testing | Peptadex
Semaglutide and tirzepatide are being studied for alcohol use disorder, opioid use disorder, and nicotine addiction. Here's what the active trials are actually testing.
FDA PCAC July 2026: What to Expect for BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon, DSIP | Peptadex
The FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to review 7 peptides for compounding eligibility. Here's what's on the agenda.
Foundayo (Orforglipron) Review: The First Oral GLP-1 Pill With No Food Restrictions | Peptadex
Foundayo (orforglipron) was FDA-approved April 1, 2026. Here's what the Phase 3 NEJM data says, how it compares to Wegovy, and what $149/month means for patients.
DSIP (Delta Sleep-Inducing Peptide): Complete Research Guide 2026 | Peptadex
DSIP is a neuropeptide linked to sleep regulation and stress response. Learn what research says and why it's now on the FDA's July 2026 advisory panel.
Epitalon and Telomeres: New 2026 PMC Research + July FDA Panel Preview | Peptadex
A new PMC study confirms Epitalon increases telomere length in human cell lines via telomerase upregulation. With the July 24 FDA panel approaching, here's what the science shows.
Amycretin: Novo Nordisk's Next Weight Loss Drug After Wegovy (Phase 3 Update) | Peptadex
Amycretin is Novo Nordisk's GLP-1/amylin dual agonist now in Phase 3. Phase 2 showed 14.5% weight loss. Here's what makes it different from semaglutide and when to expect results.
BPC-157 for Joint Recovery: What Two 2026 Systematic Reviews Actually Found | Peptadex
Two peer-reviewed systematic reviews published in 2026 examined BPC-157 for musculoskeletal and joint recovery. Here is a factual breakdown of the evidence and its limits.
Is BPC-157 Legal Again? FDA Category 2 Removal Explained (April 2026) | Peptadex
BPC-157 is being removed from the FDA's Category 2 list effective April 22, 2026. Here's what that actually means, what's still pending, and the July advisory panel timeline.
Peptide Market in 2026: Clinical Trials, Search Trends, and What Is Coming Next | Peptadex
The peptide therapeutics market is surging in 2026 with 10M+ monthly searches, 150+ trials, and major FDA approvals. Here is the full landscape.
Retatrutide vs Tirzepatide vs Semaglutide: 2026 Head-to-Head Data Compared | Peptadex
Compare retatrutide, tirzepatide, and semaglutide using the latest Phase 3 data. See weight loss percentages, mechanisms, and side effects side by side.
Which Peptides Are Legal to Compound in 2026? Complete Category Guide | Peptadex
A complete guide to which peptides are legal for compounding in 2026, including Category 1 vs Category 2 distinctions and the pending reclassification.
MOTS-c Peptide: The Exercise Mimetic for Longevity and Metabolism | Peptadex
MOTS-c is a mitochondrial peptide that mimics exercise at the cellular level. Learn about its benefits for metabolism, aging, and longevity in this guide.
Oral GLP-1 Drugs in 2026: Orforglipron, Oral Wegovy, and the End of Injections | Peptadex
Oral GLP-1 drugs are reshaping weight loss treatment in 2026. Compare orforglipron (Foundayo), oral semaglutide, and what these pills mean for patients.
FDA Peptide Reclassification 2026: Complete Guide to What Changed | Peptadex
Everything you need to know about the 2026 FDA peptide reclassification from Category 2 to Category 1, including which peptides are affected and current status.
GHK-Cu: The Anti-Aging Peptide With 1,016% Search Growth in 2026 | Peptadex
GHK-Cu is the fastest-growing peptide search term of 2026. Learn what the copper peptide does for skin, hair, and longevity based on current research.
Buying Peptides Online: Gray Market Risks and How to Protect Your Health | Peptadex
The gray market for peptides sourced from China is under media scrutiny. Learn what you need to know about peptide quality, testing, and safety in 2026.
BPC-157 Dosage Guide: Protocols, Timing, and What Research Shows
A comprehensive look at BPC-157 dosing ranges, administration routes, cycle lengths, and what preclinical and early clinical research has used in study protocols.
Peptide Stacking: Which Peptides Can You Combine?
An educational overview of peptide stacking — what it means, which combinations have been studied together, which to avoid, and how to research stacks effectively.
What is Biological Age? How Peptide Users Track It
An educational guide to biological age — what it means, how it differs from chronological age, how it is measured, and why longevity-focused peptide users monitor it.
Retatrutide: The Triple Agonist That Lost Participants 71 lbs in Phase 3
Eli Lilly's retatrutide is the first GIP/GLP-1/glucagon triple receptor agonist to reach Phase 3 trials. Here's what the TRIUMPH data shows and what comes next.
What is BPC-157? A Complete Guide
Learn about BPC-157, a synthetic peptide derived from a protein found in gastric juice, its research history, and what scientists have discovered in preclinical studies.
Semaglutide vs Tirzepatide: Comparing GLP-1 Peptides
A factual comparison of semaglutide and tirzepatide, two GLP-1 receptor agonist peptides that have been studied in clinical trials for metabolic health.
Beginner's Guide to Peptide Reconstitution
An educational overview of how research peptides are reconstituted in laboratory settings, including common solvents, sterile technique, and storage considerations.
CJC-1295 + Ipamorelin Stack: What You Should Know
An educational overview of CJC-1295 and Ipamorelin, two growth hormone secretagogue peptides frequently studied together in research contexts.
Understanding Peptide Clinical Phases: From Preclinical to FDA
A guide to understanding the drug development pipeline, from early preclinical research through Phase I, II, III clinical trials, and FDA approval.
Top 5 Peptides for Recovery in 2026
An educational overview of five peptides frequently referenced in recovery-related research, including their current clinical status and what studies have explored.
How to Read Your Peptide-Related Lab Results
An educational guide to understanding common laboratory biomarkers that are monitored in clinical and research settings involving peptide compounds.
Peptide Safety: Understanding Side Effects and Contraindications
An educational overview of safety considerations, commonly reported side effects, and general contraindications associated with various peptide classes.